Spontaneous pneumothorax associated with COVID-19 pneumonia: a single-centre retrospective study
Spontaneous pneumothorax (SP) is a rare complication of COVID-19 pneumonia; it affects both intubated and non-intubated patients. The pathogenesis includes barotrauma and pneumatocele formation. In the following article, we present case series of 18 patients with COVID-19 associated pneumothorax - a detailed demographic and clinical analysis were performed. The study revealed that men were more affected than women, especially above the age of 55 years; whilst, the distribution of intubated patients and those with spontaneous breathing were equal. Importantly, tube thoracostomy was the preferred method of treatment. The lethal outcome was observed in all patients on mechanical ventilation, due to the severe course of the underlying disease. The occurrence of pneumothorax in patients with COVID-19 is associated with poorer outcome of the disease, especially in those placed on mechanical ventilation.
Zhang G, Zhang J, Wang B, et al. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res 2020;21:74.
WHO. COVID-19 Weekly Epidemiological Update. December 2020.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–13.
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novelcoronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-9.
Hameed M, Jamal W, Yousaf M, et al. Pneumothorax in Covid-19 pneumonia: A case series. Respir Med Case Reports 2020;31:101265.
Hollingshead C, Hanrahan J. Spontaneous pneumothorax following COVID-19 pneumonia. IDCases 2020;21:e00868.
Ferreira JG, Rapparini C, Moreno Gomes B, et al. Pneumothorax as a late complication of COVID-19. Rev Inst Med Trop S Paulo 2020;62:5-9.
Martinelli AW, Ingle T, Newman J, et al. COVID-19 and pneumothorax: a multicentre retrospective case series. Eur Respir J 2020;56:2002697.
MacDuff A, Arnold A, Harvey J. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. Thorax 2010;65:ii18-31.
Yang F, Shi S, Zhu J, et al. Analysis of 92 deceased patients with Covid-19. J Med Virol 2020;92:2511-15.
Nicola M, Neill NO, Sohrabi C, et al. Evidence based management guideline for the COVID-19 pandemic - Review article. Int J Surg 2020;77:206–16.
Murayama S, Gibo S. Spontaneous pneumomediastinum and Macklin effect: Overview and appearance on computed tomography. World J Radiol 2014;6:850-4.
Xu Z, Shi L, Wang Y, Zhang J, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420-2.
Sihoe ADL, Wong RHL, Lee ATH, et al. Severe acute respiratory syndrome complicated by spontaneous pneumothorax. Chest 2004;125:2345–51.
Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology 2020;295:685- 91.
Li L, Li R, Wu Z, et al. Therapeutic strategies for critically ill patients with COVID-19. Ann Intensive Care 2020;10:45.
McCool FD. Diseases of the diaphragm, chest wall, pleura and mediastinum. In: Goldman L, Schafer AI, editors. Goldman-Cecil medicine. 26th ed. Philadelphia: Elsevier; 2020. p. 602-12.
Mallick T, Dinesh A, Engdahl R, Sabado M. COVID-19 complicated by spontaneous pneumothorax. Cureus 2020;12:e9104.
Rohailla S, Ahmed N, Gough K. SARS-CoV-2 infection associated with spontaneous pneumothorax. CMAJ 2020;192:e510.
Ucpinar BA, Sahin C, Yanc U. Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: case report. J Infect Public Health 2020;13:887-9.
- Abstract views: 150
- PDF: 73
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.